Effects of Berberine on Cardiometabolic Outcomes

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorUniversity of Central Lancashire

About this trial

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Berberine may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.

Eligibility criteria

Qualifiers

Healthy

Between 18 & 65 years

Non-smoker

BMI < 30

Disqualifiers

Pregnancy

Diabetes or any other metabolic/ uncontrolled hypertensive conditions

Food allergies to berberine

Habitual consumption of berberine

Trial design

Treatments tested in this trial

  • Berberine
  • Placebo

Treatment groups

40 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators